+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Companion Diagnostics Market 2020-2024- Product Image

Global Companion Diagnostics Market 2020-2024

  • ID: 5232345
  • Report
  • December 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now
Market Growth Has Experienced a Change of 25.29% YoY in 2020

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • MORE
The companion diagnostics market is poised to grow by $5.74 billion during 2020-2024 progressing at a CAGR of 26% during the forecast period.

This report on the companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector. In addition, rising use of personalized medicine is anticipated to boost the growth of the market as well.

The companion diagnostics market analysis includes end-user segment and geographical landscapes.

The companion diagnostics market is segmented as below:

By End-user
  • Life science
  • Health centers
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on the companion diagnostics market covers the following areas:
  • Companion diagnostics market sizing
  • Companion diagnostics market forecast
  • Companion diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019-2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Life science - Market size and forecast 2019-2024
  • Health centers - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by End-user
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019-2024 ($ million)
13: Global market: Year-over-year growth 2019-2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: End user - Market share 2019-2024 (%)
22: Comparison by End user
23: Life science - Market size and forecast 2019-2024 ($ million)
24: Life science - Year-over-year growth 2019-2024 (%)
25: Health centers - Market size and forecast 2019-2024 ($ million)
26: Health centers - Year-over-year growth 2019-2024 (%)
27: Others - Market size and forecast 2019-2024 ($ million)
28: Others - Year-over-year growth 2019-2024 (%)
29: Market opportunity by End user
30: Customer landscape
31: Market share by geography 2019-2024 (%)
32: Geographic comparison
33: North America - Market size and forecast 2019-2024 ($ million)
34: North America - Year-over-year growth 2019-2024 (%)
35: Europe - Market size and forecast 2019-2024 ($ million)
36: Europe - Year-over-year growth 2019-2024 (%)
37: Asia - Market size and forecast 2019-2024 ($ million)
38: Asia - Year-over-year growth 2019-2024 (%)
39: ROW - Market size and forecast 2019-2024 ($ million)
40: ROW - Year-over-year growth 2019-2024 (%)
41: Key leading countries
42: Market opportunity by geography ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Abbott Laboratories - Overview
50: Abbott Laboratories - Business segments
51: Abbott Laboratories - Key offerings
52: Abbott Laboratories - Key customers
53: Abbott Laboratories - Segment focus
54: Agilent Technologies Inc. - Overview
55: Agilent Technologies Inc. - Business segments
56: Agilent Technologies Inc. - Key offerings
57: Agilent Technologies Inc. - Key customers
58: Agilent Technologies Inc. - Segment focus
59: bioMérieux SA - Overview
60: bioMérieux SA - Business segments
61: bioMérieux SA - Key offerings
62: bioMérieux SA - Key customers
63: bioMérieux SA - Segment focus
64: F. Hoffmann-La Roche Ltd. - Overview
65: F. Hoffmann-La Roche Ltd. - Business segments
66: F. Hoffmann-La Roche Ltd. - Key offerings
67: F. Hoffmann-La Roche Ltd. - Key customers
68: F. Hoffmann-La Roche Ltd. - Segment focus
69: Illumina Inc. - Overview
70: Illumina Inc. - Product and service
71: Illumina Inc. - Key offerings
72: Illumina Inc. - Key customers
73: Illumina Inc. - Segment focus
74: Myriad Genetics Inc. - Overview
75: Myriad Genetics Inc. - Business segments
76: Myriad Genetics Inc. - Key offerings
77: Myriad Genetics Inc. - Key customers
78: Myriad Genetics Inc. - Segment focus
79: QIAGEN NV - Overview
80: QIAGEN NV - Business segments
81: QIAGEN NV - Key offerings
82: QIAGEN NV - Key customers
83: QIAGEN NV - Segment focus
84: Siemens Healthineers AG - Overview
85: Siemens Healthineers AG - Business segments
86: Siemens Healthineers AG - Key offerings
87: Siemens Healthineers AG - Key customers
88: Siemens Healthineers AG - Segment focus
89: Sysmex Corp. - Overview
90: Sysmex Corp. - Product and service
91: Sysmex Corp. - Key offerings
92: Sysmex Corp. - Key customers
93: Sysmex Corp. - Segment focus
94: Thermo Fisher Scientific Inc. - Overview
95: Thermo Fisher Scientific Inc. - Business segments
96: Thermo Fisher Scientific Inc. - Key offerings
97: Thermo Fisher Scientific Inc. - Key customers
98: Thermo Fisher Scientific Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • MORE
The analyst recognizes the following companies as the key players in the global companion diagnostics market: Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc.

According to one of the team's analysts: The latest trend gaining momentum in the market is rising occurrence of breast cancer.

According to the report, one of the major drivers for this market is the rising use of personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Siemens Healthineers AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll